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stance use and crime over time. Study retention was compa-
rable in both groups.  Conclusion: QCT is as effective as vol-
untary treatment provided in the same services in reducing 
substance use and crime.  Copyright © 2009 S. Karger AG, Basel 
 Introduction 
 This international study presents the findings of an 
evaluation of quasi-compulsory drug treatment (QCT) 
arrangements for substance-dependent offenders com-
pared to voluntary treatment in the United Kingdom, It-
aly, Austria, Germany, and Switzerland. We define QCT 
as substance abuse/dependence treatment that is moti-
vated, ordered, or supervised by the criminal justice sys-
tem but takes place in a non-prison context. The goal of 
the study is to produce evidence for policy and practice 
on QCT of substance-dependent offenders in Europe as 
policy and practice are currently implemented in the ab-
sence of reliable evidence in many countries  [1] .
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 Abstract 
 Aim: This study evaluates quasi-compulsory drug treatment 
(QCT) arrangements for substance-dependent offenders re-
ceiving treatment instead of imprisonment in comparison to 
voluntary treatment within five European countries.  Meth-
ods: Participants were interviewed with the European Ad-
diction Severity Index, the ASI-crime module, questions on 
perception of pressure and self-efficacy, and the Readiness-
to-Change Questionnaire at treatment entry and after 6, 12, 
and 18 months.  Results: Reductions in substance use and 
crime as well as improvements in health and social integra-
tion were observed in QCT and voluntary treatment groups. 
After controlling for various factors, subjects in the QCT and 
the comparison group showed similar reductions in sub-
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 To date, much attention has been paid to the use of the 
criminal justice system to direct drug-related offenders 
into treatment in many countries worldwide  [2–6] . In Eu-
rope, QCT is applied in a variety of ways. England uses 
sentences which enable courts to order an offender to en-
ter treatment for a specified period as an alternative to 
some other sentence, usually imprisonment. In Austria, 
Germany and Switzerland, legal arrangements are in 
place that can broadly be described as ‘therapy instead of 
punishment’, with the possibility to suspend prosecution 
or sentence on the condition that the offender enters 
treatment. In Italy, prison sentences of no more than 4 
years, or the last 4 years of a longer prison sentence, can 
be replaced by a period in judicially supervised drug 
treatment but require the informed consent of the offend-
er. In contrast to the Dutch SOV system, in which offend-
ers may be placed in treatment institutions without their 
consent. European arrangements for QCT differ from the 
drug courts established in many states of the USA, in that 
they are not limited to drug offenders and are often used 
for persistent offenders, who would be excluded from sev-
eral of the American drug court systems.
 Literature on QCT shows that substance abuse and 
crime are often linked, however the explanation for and 
direction of this link are not clear  [7–14] . In general, stud-
ies – predominately from English-speaking countries – 
tend to agree that QCT can be effective in reducing sub-
stance use and crime, and that it can improve health and 
social integration. They suggest that QCT is at least as ef-
fective as voluntary treatment  [15–19] and that legal com-
pulsion can improve retention in treatment  [20, 21] . Lon-
ger retention has repeatedly been associated with im-
proved outcome  [22–26] . In contrast, literature from 
other countries (e.g. Germany, The Netherlands) tends to 
be more pessimistic about the effectiveness of QCT  [1] .
 It must be highlighted that a large proportion of the 
research based on the topic of mandated vs. voluntary 
treatment for substance users is non-empirical in nature 
 [27] , with the majority of empirical studies failing to use 
adequate comparison groups  [28] . These facts indicate 
the importance of developing more sophisticated empir-
ical methods for evaluating QCT as, in addition, previous 
studies tend to use relatively short follow-up periods  [29] . 
Several studies suggest that perceived coercion  [16] and 
motivation  [30–32] are important in predicting outcome 
and that perceived coercion cannot be directly inferred 
from referral source  [31–36] ; however, investigations fo-
cusing on these variables are comparatively rare. In addi-
tion, several studies refer to the additional difficulties of 
providing treatment for substance users in the context of 
the criminal justice system as this involves the potential 
for conflict, misunderstanding, and inadequate sharing 
of information  [37–40] . QCT arrangements among dif-
ferent countries differ in the stage at which people are 
encouraged to begin treatment, the level of compulsion 
used, and the types of crimes that are of focus  [41, 42] . 
These methodical and political differences among vari-
ous countries might explain the almost non-existent in-
ternational comparisons of QCT arrangements.
 In summary, a review of previous research suggests 
that more multimethod, multicenter studies of QCT are 
needed in order to inform policy and practice  [1] . There 
is a need for more studies worldwide before more solid 
conclusions can be drawn regarding the effectiveness of 
substance abuse treatment under legal coercion  [28] . 
 To address the lack of European cross-cultural QCT 
outcome data and to meet the mentioned methodological 
weaknesses above, we designed a European multicenter 
study to test the following hypotheses: (1) The QCT group 
and the comparison group (people who are not in QCT, 
but are going through treatment in centers where people 
in the QCT group are treated) will show reductions in 
crime and substance use as well as increases in health and 
socialization. (2) If other factors are statistically con-
trolled, the QCT group will have outcomes (crime and 
substance use) that differ from those of the comparison 
group. (3) If other factors are statistically controlled, the 
QCT group will display better retention than the com-
parison group.
 Methods 
 Services and Participant Selection 
 Services from the United Kingdom, Italy, Austria, Germany, 
and Switzerland were selected if they treated participants eligible 
for the experimental QCT and the comparison group. The QCT 
group was defined as participants receiving treatment on court 
order (in- or outpatient), as an optional alternative to imprison-
ment or other punishment, in a regular treatment institution. The 
comparison group was defined as persons entering voluntarily 
treatment institutions.
 Inpatient treatment included almost exclusively abstinent-ori-
ented drug addiction treatment after detoxification. Drug addic-
tion treatment programs ranged from occupational therapy with 
few possibilities for drug counseling to highly structured indi-
vidual and group therapy programs. Outpatient treatment main-
ly included weekly to monthly drug counseling. Participants in 
outpatient treatment with opiate addiction were predominantly 
treated in substitution programs. In the voluntary group, treat-
ment length was depending on treatment concepts (inpatients) or 
individual decisions (outpatients). Non-compliance in the QCT 
group depended on the respective countries’ regulations, and 
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therefore QCT participants were at risk of being sentenced to pris-
on in most countries. Participants in the QCT group were includ-
ed to the study at entry to treatment (having or awaiting a court 
sentence for QCT) and provided informed consent to participate 
in the study and for the use of their medical and police records 
(intention-to-treat design). All participants were asked to provide 
informed consent at treatment entry, were assured that all infor-
mation would be handled confidentially, and were informed that 
they had the right to withdraw at any time without any conse-
quences to their treatment and/or court sentence (if applicable). 
The study protocol was approved by the national or local ethics 
committees. All participants were exponentially paid for each fol-
low-up interview between EUR 10 and 20 at 6, 12, and 18 months 
(FU1–3) in order to promote retention in the study.
 Measures 
 Participants were interviewed using an amended version of 
the European Addiction Severity Index (Europ-ASI  [43] ) and the 
ASI-crime module (ASI-C  [44] ), both structured interviews that 
contain questions relevant to the participants’ problems with sub-
stance abuse and its possible related and other crimes. ‘Poly drug 
use’ in the Europ-ASI refers to the primarily combined drug use 
of two or more psychoactive substances to achieve a particular ef-
fect. Moreover, participants were assessed with a questionnaire 
from Hiller et al.  [32] on perception of pressure (pressure from 
legal authorities, family or friends, employer(s), themselves, and 
others), an adapted version of the Proactive Coping Scale  [45] to 
measure the subjects’ belief of being capable of attaining certain 
goals (self-efficacy), and the Readiness-to-Change Questionnaire 
to measure the readiness to quit substance use  [46] . The partici-
pant interviews were completed face-to-face by external inter-
viewers (independent from the treatment institution) who were 
trained in the use of the Europ-ASI. Interview guidelines and 
questionnaires unavailable in the required language were back-
translated by native speaking experts in the research field. Par-
ticipants were anonymously coded by a complex coding system 
that contained re-identification information about their treating 
country and institution, number within the institution, and study 
group classification.
 Data Collection and Clearance 
 Study data were collected in the respective countries ( table 1 ) 
and sent to Zurich, Switzerland, for integration into the central-
ized database. Before the data were analyzed, a two-step control 
and correction process was administered. In the first step, data 
were checked for dual entry of the same participant, errors in 
participant identification, changes from one treatment service to 
another, and missing participants. In the second step, all data 
were controlled for missing values and content errors. A special 
‘query procedure’ was developed in order to systematically col-
lect corrections and enter them into the database. In many cases, 
two to three attempts were made before all corrections were in-
tegrated.
 Statistical Analyses 
 Study outcome data were analyzed according to the ‘intention-
to-treat principles’, applying the ‘last observation carried for-
ward’ (LOCF) method. Through this method, for each individual, 
missing values are replaced by the last observed value for each 
variable in order to avoid individuals with more severe baseline 
characteristics dropping out of further study outcome analyses. 
The QCT and the comparison group baseline characteristics were 
compared with independent sample t and   2 tests, respectively. 
Study outcomes for the different time points, baseline and follow-
up 1–3, were analyzed by general linear model procedures for re-
peated measures. Hypothesis 2 was analyzed by a general linear 
model for ‘substance use in the last 30 days’ at the 4 time points 
as within factor, and ‘group affiliation’ (QCT or comparison 
group) as the between factor, including numerous baseline co-
variates, of those some are presented in  table 2 . Analogous analy-
ses were performed for ‘crimes in the last 6 months’ at the 4 time 
points. Moreover, means and standard deviations were estimated 
in the controlled general linear models for hypothesis 2 and Bon-
ferroni-corrected ANOVAs were performed for these estimated 
values.
 The reasons for leaving treatment were documented immedi-
ately after a dropout, and percents of dropout reasons for each 
follow-up time point were calculated. Study retention for hypoth-
esis 3 was compared with similar general linear models used for 
hypothesis 2. Cox regression survival analyses were performed to 
Group Intake
n
FU1
n (%)
FU2
n (%)
FU3
n (%)
Completed interviews for countries
United Kingdom 157 106 (67.5) 100 (63.7) 94 (59.9)
Italy 300 216 (72.0) 179 (59.7) 160 (53.3)
Austria 150 83 (55.3) 74 (49.3) 67 (44.7)
Switzerland 85 74 (87.1) 73 (85.9) 67 (78.8)
Germany 153 96 (62.7) 62 (40.5) 59 (38.6)
Total 845 575 (68.0) 488 (57.8) 447 (52.9)
Treatment status
In treatment 845 474 (56.1) 348 (46.4) 291 (37.2)
Not in treatment 0 371 (43.9) 402 (53.6) 491 (62.8)
Missing 0 0 (0.0) 95 (11.2) 63 (7.5)
Table 1. Overview of completed study
interviews
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identify baseline predictors for treatment retention (days re-
mained in treatment) in the QCT and the comparison group. All 
data were analyzed using the statistical software package SPSS, 
version 15.
 Results 
 Groups’ Baseline Characteristics 
 Overall, as expected, there were more male than fe-
male participants (see  table 2 for detailed baseline char-
acteristics). The mean years of school education in the 
QCT group was lower than that in the comparison group 
as was the longest period of regular employment. There 
was more medical care in the comparison group (QCT: 
46.8%, comparison group: 54.1%;   2 = –2.101, d.f. = 1,
p  ! 0.05) and significantly more individuals in outpa-
tient treatment in the QCT group than in the comparison 
group.
 Poly drug users were of similar frequency in the QCT 
and the comparison group. Mean years of lifetime crack 
use, although crack users were not very prevalent (QCT: 
4.0%, comparison group: 2.4%), was higher in the QCT 
group. Problematic alcohol users were of lower prevalence 
in the QCT group (QCT: 3.5%, comparison group: 6.5%; 
  2 = –3.502, d.f. = 1, p  ! 0.001), and there were fewer mean 
years of excessive alcohol use in the QCT group ( table 2 ).
 At baseline, the participants in the QCT group had 
committed more severe crimes in the past than the vol-
untary participants, showed higher overall perceived 
pressure (QCT: 12.36  8 3.78, comparison group: 11.25  8 
3.30; t = 4.571, d.f. = 842, p  ! 0.001), but did not differ in 
perceived self-efficacy and stages of change (data not 
shown).
 Study Outcomes 
 A significant reduction in substance use is observed 
for the QCT group as well as the voluntary comparison 
Table 2. Groups’ baseline characteristics
QCT Comparison F/2 Sig.
Male, % 53 62 1.301 n.s.
Age 31.787.5 31.087.6
Married, % 11.0 11.3 0.060 n.s.
Non-nationals, % 3.4 4.2 –0.568 n.s.
Years of education 9.682.1 10.182.2 2.980 <0.01
Longest period of unemployment 4.784.9 3.284.2 4.459 <0.001
Homeless, % last 30 days 20.6 14.2 2.425 <0.05
Chronic health problems last 6 months, % 51.9 47.6 1.274 n.s.
Received medical care last 6 months, % 46.9 54.1 –2.101 <0.05
In outpatient treatment, % 50.0 34.9 19.595 <0.001
Substance use
Poly drug user, %a 24.9 21.9 1.223 n.s.
Heroin user, %a 35.0 37.5 1.261 n.s.
Lifetime years of heroin use 6.985.8 6.285.5 2.894 n.s.
Cocaine user, %a 18.9 15.4 0.258 n.s.
Lifetime years of cocaine use 5.185.1 4.785.0 0.968 n.s.
Crack user, %a 4.0 2.4 0.967 n.s.
Lifetime years of crack use 2.083.6 0.982.4 4.525 <0.001
Methadone prescription, % 21.2 25.6 –1.405 n.s.
Years of excessive alcohol 3.185.7 4.588.0 2.623 <0.01
Conducted crimes
High severity crimes ever, %b 46.3 40.3 6.170 <0.001
Medium severity crimes ever, %c 30.2 30.1 0.006 n.s.
Low severity crimes ever, %d 23.5 29.6 –3.832 <0.001
a Percents with main substance of abuse. b Category included for example, burglary, firearm and other weap-
ons offences. c Category included forgery, domestic crime. d Category included for example, nuisance crimes, 
prostitution, pimping, and shoplifting.
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group (see  table 3 for more detailed study outcomes), 
with a somewhat higher reduction in the QCT group 
over the entire 18 months. In both groups, the major re-
duction occurs during the first 6 months (between in-
take and FU1), thereafter the level of use remains rela-
tively unchanged ( table 3 ). The reduction follows differ-
ent patterns in participants receiving in- and outpatient 
treatment. While inpatients show a major reduction 
during the first 6 months and an overall larger reduc-
tion (F = 28.471, d.f. = 1, p  ! 0.001), outpatients take 
more time to recover and reach major reductions be-
tween the 6th and 12th month ( table 3 ). For those ad-
dicted to opiates, prescription of substitution substance 
did not change over the 18 months (QCT: F = 0.080,
d.f. = 3, n.s.; comparison group: F = 1.958, d.f. = 3, n.s.) 
and did not differ between groups over time (F = 0.471, 
d.f. = 1, n.s.). There were differences between in- and 
outpatients in frequency of participants with prescribed 
methadone (F = 31.274, d.f. = 1, p  ! 0.001), with higher 
prescription frequency in outpatients at all time points 
(data not shown).
 The reduction of crime was also considerably high in 
both groups, with a higher reduction over the entire 18 
months in the QCT group. Again, participants receiving 
inpatient treatment showed a major reduction during the 
first 6 months (inpatients: F = 61.169, d.f. = 3, p  ! 0.001; 
outpatients: F = 24.411, d.f. = 3, p  ! 0.001), and an overall 
larger reduction (F = 13.678, d.f. = 1, p  ! 0.001) as com-
pared to outpatients. There were slight improvements in 
overall health and rather stronger improvements in em-
ployment and mental health status in both groups ( ta-
ble 3 ). The overall health status and the overall perceived 
pressure were higher in the QCT group than in the com-
parison group at all time points. However, there were no 
Table 3. Study outcomes (last observation carried forward)
Outcome/group Intake Follow-up 1 Follow-up 2 Follow-up 3 Differences baseline
to follow-up 3
Between study
groups comparisons
F sig. F sig.
Main substance use
QCT 17.4813.6 11.4813.5 9.2812.7 9.5812.7 52.113 <0.001
CG 15.4812.2 8.5812.1 8.3811.9 8.8812.2 48.412 <0.001 4.960 <0.05
Percent of ≥1 crime
QCT, % 59.9 36.4 33.1 33.1 51.722 <0.001
CG, % 41.8 21.4 19.7 22.1 37.253 <0.001 29.258 <0.001
Overall healtha
QCT 2.988.6 3.789.4 2.487.4 2.387.3 3.672 <0.05
CG 5.5810.9 6.6812.1 4.7810.4 4.5810.3 5.790 <0.001 20.582 <0.001
Employment statusb
QCT 5.6810.6 8.0811.6 8.6811.2 9.0811.5 14.368 <0.001
CG 3.388.0 7.2811.3 8.4811.4 9.6811.8 36.624 <0.001 1.268 n.s.
Mental healthc
QCT, % 56.9 47.3 42.2 45.7 12.874 <0.001
CG, % 58.9 44.7 42.1 45.4 14.551 <0.001 0.007 n.s.
Self-efficacy
QCT, % 3.4; 0.5 3.5; 0.5 3.4; 0.5 3.4; 0.5 0.624 n.s.
CG, % 3.4; 0.6 3.4; 0.6 3.5; 0.6 3.4; 0.5 2.777 n.s. 0.001 n.s.
Stages of change
QCT, % 2.2; 0.8 2.3; 0.8 2.2; 0.9 2.2; 0.9 1.871 n.s.
CG, % 2.2; 0.8 2.2; 0.9 2.2; 0.9 2.2; 0.9 0.728 n.s. 1.441 n.s.
Overall perceived pressure
QCT, % 12.4; 3.8 12.1; 3.9 12.2; 3.9 12.2; 3.9 0.846 n.s.
CG, % 11.2; 3.3 11.0; 3.4 11.0; 3.6 10.9; 3.4 2.350 n.s. 29.408 <0.001
QCT = Quasi-compulsory drug treatment; CG = comparison group.
a Days listed as sick during the last month. b Mean working days in the last month. c Percents with serious psychiatric problems in 
the last month.
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significant differences for these groups in employment, 
mental health status, perceived self-efficacy, and stages of 
change.
 The GLM for ‘substance use in the last 30 days’, con-
trolled for baseline factors, revealed no significant differ-
ences for groups over time (F = 2.425, d.f. = 3, n.s.) and 
no significant differences between groups in the estimat-
ed means over time (F = 1.467, d.f. = 1, n.s.). The GLM for 
the reduction of ‘crimes in the last 6 months’ was statisti-
cally significant for groups over time (F = 3.732, d.f. = 3, 
p  ! 0.05) and was highly significant between groups in 
the estimated means (F = 32.643, d.f. = 1, p  ! 0.001).
 Dropouts and Retention 
 Within the 18 months following the intake, 47.1% of 
all participants dropped out of the study, with a major 
loss during the first 6 months ( table 1 ). 4.9% partici-
pants in the QCT group and 1.7% participants in the 
voluntary group were arrested (  2 = 2.631, d.f. = 1, p  ! 
0.01). Study retention was similar for both groups (F = 
0.590, d.f. = 1, n.s.). However, survival analyses on treat-
ment retention (days remained in treatment) yielded 
different baseline variables for the QCT and the com-
parison group. In the QCT group, criminal behavior last 
6 months (OR = 2.375, CI = 1.04–5.42, p  ! 0.05), per-
ceived pressure from the employer (OR = 2.234, CI = 
1.47–3.39, p  ! 0.001), and treatment in Italy (OR = 2.108, 
CI = 1.01–2.79, p  ! 0.001) were significant baseline pre-
dictors for treatment retention. In the comparison 
group, the significant baseline predictors were being cit-
izen of the respective country (OR = 4.283, CI = 1.08–
16.48, p  ! 0.05), perceived legal pressure (OR = 1.562,
CI = 1.17–2.00, p  ! 0.01), and again, treatment in Italy 
(OR = 3.484, CI = 1.70–7.16, p  ! 0.01).
 Discussion 
 Overall, we were able to provide data and results from 
an extensive number of individuals in QCT and of ade-
quate comparison groups from various treatment sites 
within five European countries, and we followed most of 
them for 18 months. Results demonstrated that there 
were reductions in substance use and crimes as well as 
improvements in overall and mental health and in em-
ployment status (social integration) in the QCT and in 
the comparison group. This is in line with other studies 
that suggest that QCT was at least as effective as volun-
tary treatment  [15–19] . In line with other studies [e.g.  47 ], 
higher reductions of substance use were found for inpa-
tient-treated than for outpatient-treated individuals in 
the first 6 months after treatment entry. Reductions of 
crime in the QCT and the comparison group were similar 
after controlling for various factors. One interpretation 
of this finding is that subjects in the QCT and the com-
parison group respond to a similar extent in terms of re-
duction in crimes; however, as individuals in QCT en-
tered treatment with a higher crime rate, they also end up 
with higher crime rates after 18 months.
 Improvements in mental health did not differ be-
tween groups and improved extensively in the first treat-
ment period, as was expected based on results of studies 
on the course of substance-using populations in treat-
ment  [47] . Interestingly, employment status improved 
over time, as expected based on other studies  [15–19] , but 
did not differ between groups. However, the comparison 
group, on average, had more sick days than did subjects 
in the QCT group. These results must be confirmed in 
future studies as comparable investigations using ade-
quate comparison groups and including employment 
status and numbers of sick days have not been conduct-
ed. Surprisingly, perceived self-efficacy and overall per-
ceived pressure did not substantially change over time. 
Less surprising was the fact that the stages of change 
characteristics in both groups did not change over time 
either, since the stages of change concept has often been 
criticized [e.g.  48 ].
 Study retention did not differ between the QCT and 
the comparison group. This result supports some of our 
previous results  [49] in which no differences in reten-
tion were found. However, survival analyses on treat-
ment retention yielded interesting differences in some 
baseline outcome predictors, which have to be further 
investigated. Taken together, perceived pressure was 
rather unrelated to retention, as observed by other au-
thors  [50] .
 One limitation of the current study was that frequen-
cies of substance use were based on self-reports and 
could not be systematically collected by urine analyses. 
Similarly, crime measures were based on the ASI crime 
module, a relatively crude measure of self-reports. More-
over, as with all multicenter studies, data collection 
from different treatment sites, underlying various so-
ciocultural and jurisdictional influences, may vary in 
ways that are difficult to control. However, the strategy 
to integrate data from different treatment sites within 
different countries with different legal situations for 
QCT sentencing policies and possibilities was an overall 
success.
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 According to the main study results, we conclude 
that QCT is effective in reducing substance use and 
crime and in improving health and social integration. 
Moreover, QCT is as effective in reducing substance use 
and crimes when compared to a voluntary comparison 
group treated in the same institutions after controlling 
for various factors discussed in the QCT literature and 
factors for which the groups showed differences at base-
line. Therefore, offering substance-dependent offenders 
the option to receive treatment is an effective alternative 
to imprisonment. Typically, the majority of substance-
dependent prison inmates resume drug use and crimi-
nal activities after release to the community [e.g.  28 ]. 
Such relapses were less common in offenders who en-
tered QCT.
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